Table 1.
Parameters | Case number | PLCB1 expression
|
χ2 | P-value | |
---|---|---|---|---|---|
Low | High | ||||
Overall | 141 | 61 | 80 | ||
Sex | |||||
Male | 126 | 54 | 72 | 0.079 | 0.778 |
Female | 15 | 7 | 8 | ||
Age (years) | |||||
<60 | 108 | 46 | 62 | 0.084 | 0.771 |
≥60 | 33 | 15 | 18 | ||
Tumor size (cm) | |||||
<5 | 77 | 37 | 40 | 1.585 | 0.208 |
≥5 | 64 | 24 | 40 | ||
Cirrhosis | |||||
Yes | 89 | 38 | 51 | 0.031 | 0.859 |
No | 52 | 23 | 29 | ||
Tumor differentiation | |||||
Well | 16 | 7 | 9 | 1.873 | 0.392 |
Moderate | 102 | 47 | 55 | ||
Poor | 23 | 7 | 16 | ||
Clinical stage (T stage) | |||||
I | 22 | 15 | 7 | 6.69 | 0.0352* |
II | 47 | 19 | 28 | ||
III+IV | 72 | 27 | 45 |
Note:
P<0.05.
Abbreviations: HCC, hepatocellular carcinoma; PLCB1, phospholipase C, β1.